J&J Beats Bid For New Trial In Philly Risperdal Case
A Philadelphia judge declined to rehear a suit by a teenage patient who claimed the antipsychotic drug Risperdal made by Johnson & Johnson subsidiary Janssen Pharmaceuticals Inc. caused him to grow...To view the full article, register now.
Already a subscriber? Click here to view full article